Transcription factor 4 (<i>TCF4</i>) expression predicts clinical outcome in <i>RUNX1</i> mutated and translocated acute myeloid leukemia
Florentien E.M. in't Hout,
Mylène Gerritsen,
Lars Bullinger,
Bert A. van der Reijden,
Gerwin Huls,
Edo Vellenga,
Joop H. Jansen
Affiliations
Florentien E.M. in't Hout
Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Centrer, Nijmegen, the Netherlands
Mylène Gerritsen
Department of Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
Lars Bullinger
Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany; Department of Hematology, Oncology and Tumorimmunology, Charité University Medicine, Berlin, Germany
Bert A. van der Reijden
Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Centrer, Nijmegen, the Netherlands
Gerwin Huls
Department of Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
Edo Vellenga
Department of Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
Joop H. Jansen
Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Centrer, Nijmegen, the Netherlands
